PYC Chart and Technical Analysis, page-43

A number of US biotechs have risen 2-4 fold in last few weeks after raising capital. Let’s hope this company gets caught up in the shift in sentiment for cashed up biotechs. I might have a go at articulating specifics tomorrow if no one else does.
A very small sell side is what I see, and anyone with shares looks to be hanging on to them and not selling into this increase….which augers well…ive been in quite a few raises and to have an arbitrage like this is very uncommon. Augers well for a jump in sp next few days imo.